1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc.

MITUY
Mitsui Chemicals, Inc.US flagOther OTC
11.21
USD
- -
- -
4.13BMarket Cap
Mitsui Chemicals, Inc.
MITUY
(Other OTC)

Recent

price

11.21

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
3,471.84
3,628.33
3,509.55
3,909.46
3,871.01
3,357.41
3,029.33
3,325.52
3,756.22
3,466.56
3,119.75
4,145.37
4,885.75
4,601.74
4,785.23
- -
2,435.37
Revenue per Share
62
-2.51
-20.34
-62.75
43.11
57.37
162.02
179.19
192.8
87.26
149
282.73
215.59
131.49
85.28
- -
77.08
Basic EPS, GAAP
76.5
15.45
-83.79
-25
51.97
261.14
147.29
75.06
136.12
109.07
251.65
-60.75
-95.19
19.32
164.24
- -
-41.05
Free Cash Flow per Basic Share
15
15
15
15
5
17.5
22.5
45.07
47.82
50.11
49.82
52.76
62.8
65
72.93
- -
35
Dividend per Share
815.11
1,025.01
989.73
912.19
952.79
991.88
1,130.75
1,265.23
1,205.46
1,246.07
1,414.54
1,648.99
1,821.41
1,954.42
1,968
- -
1,972.47
Book Value per Share
1,047.27
1,008.53
1,033.93
842.37
995.27
1,006.96
1,198.07
1,391.12
1,532.95
1,498.78
1,702.75
1,911.92
2,120.69
2,389.04
2,336.27
- -
2,360.68
Tangible Book Value per Share
401
401
401
401
400
400
400
399
395
389
388
389
385
380
378
375
380
Basic Weighted Avg Shares
1,391,713
1,454,024
1,406,220
1,566,046
1,550,076
1,343,898
1,212,282
1,328,526
1,482,909
1,349,522
1,211,725
1,612,688
1,879,547
1,749,743
1,809,164
- -
926,088
Sales/Revenue/Turnover
2.91
1.48
0.31
1.59
2.71
5.28
8.43
7.79
6.3
4.45
5.95
7.53
5.71
3.53
3.64
- -
3.91
Operating Margin (%)
69,237
62,749
43,864
48,143
48,251
48,640
44,057
45,654
49,504
76,009
76,621
84,222
92,080
95,249
99,768
- -
48,969
Depreciation Expense
24,854
-1,007
-8,149
-25,138
17,261
22,963
64,839
71,585
76,115
33,970
57,873
109,990
82,936
49,999
32,242
- -
29,311
Net Income, GAAP
24.57
53.73
- -
- -
32.03
28.65
13.89
16.12
17.83
29.93
13.5
16.08
23.14
26.67
40.5
- -
26.99
Effective Tax Rate (%)
1.79
-0.07
-0.58
-1.61
1.11
1.71
5.35
5.39
5.13
2.52
4.78
6.82
4.41
2.86
1.78
- -
3.17
Profit Margin (%)
223,678
209,804
221,488
269,959
283,209
263,951
286,155
288,221
304,604
296,160
321,267
326,876
398,842
474,000
435,244
- -
458,850
Working Capital
324,733
294,501
320,956
389,595
368,996
339,299
304,228
305,963
322,749
313,237
293,495
319,471
369,786
432,670
455,489
- -
447,771
LT Debt
431,101
415,771
428,914
409,647
471,299
443,237
514,635
587,222
631,063
609,707
682,157
807,122
883,303
984,806
970,604
- -
978,640
Total Equity
3.97
1.35
- -
- -
3.47
6.2
10.91
10.06
7.47
3.64
5.82
9.61
6.87
3.38
2.75
- -
1.59
Return on Invested Capital (%)
3.07
-0.87
- -
- -
1.86
2.63
7.51
8.05
7.18
2.91
5.77
11.32
8.02
4.62
2.34
- -
2.41
Return on Capital (%)
7.83
-0.27
-2.02
-6.6
4.62
5.9
15.26
14.95
15.51
7.07
11.19
18.47
12.36
6.93
4.34
- -
4
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
324,088
- -
228,721
LT Borrowings
432,670
- -
447,771
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
380
- -
380
Market Capitalization
859,367
853,960
743,369

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
1,150,579
- -
1,012,954
Cash, Cash Equivalents & STI
249,510
- -
207,377
Accounts Receivable, Net
365,896
- -
318,694
Inventories
451,075
- -
453,115
Total Current Liabilities
676,579
- -
554,104
Payables & Accruals
- -
- -
- -
ST Debt
324,088
- -
228,721
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
407,925
415,730
450,875
475,213
1,749,743
2025
- -
- -
- -
- -
1,809,164
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
25.23
29.18
43.58
- -
131.49
2025
- -
- -
- -
- -
85.28
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
30
- -
35
- -
65
2025
- -
- -
- -
- -
72.93
2026
- -
- -
- -
- -
- -
Similar Companies
Chokwang Paint Co., Ltd. (004910.KS)
Mahickra Chemicals Ltd. (MAHICKRA.NS)
Kawaguchi Chemical Industry Co., Ltd (4361.T)
Doosan Robotics Inc. (454910.KS)
Qingdao Gon Technology Co., Ltd. (2768.HK)
Polyplex (Thailand) Public Company Limited (PTL-R.BK)
Business
Mitsui Chemicals, Inc. manufactures and sells a broad range of petrochemicals, specialty chemicals, and industrial materials through its four primary business segments: Life & Healthcare Solutions, Mobility Solutions, ICT Solutions, and Basic & Green Materials; the Life & Healthcare Solutions segment provides vision care materials, oral care materials, nonwoven fabrics, personal care materials, agricultural chemicals including milbemectin, probenazole and simeconazole, and pharmaceutical raw materials; the Mobility Solutions segment offers elastomers, performance compounds, polypropylene compounds, composite materials, and solutions for automotive and industrial applications; the ICT Solutions segment supplies materials for semiconductors and electronic components, optical materials, lithium-ion battery materials, next-generation battery materials, and high-performance food packaging; the Basic & Green Materials segment produces ethylene, propylene, polyethylene, polypropylene, phenols, PET resins, polyurethane raw materials including 1,4-H6XDI and bio-based 1,5-pentamethylene diisocyanate, catalysts, and green chemicals such as olefin polymerization catalysts and surface modifiers. Founded in 1997 and headquartered in Tokyo Midtown Yaesu, Yaesu Central Tower, Chuo-ku, Tokyo, Japan, the company operates globally with manufacturing sites in Japan including Ichihara Works, Nagoya Works and Iwakuni-Ohtake Works, sales offices in Nagoya, Osaka and Fukuoka, and international presence across Asia, Europe and North America serving industries such as healthcare, automotive, electronics, agriculture and consumer goods. Recent developments include the launch of its second corporate venture capital fund 321Catalyst with $60 million committed for global investments in innovative startups aligned with VISION 2030 strategy in May 2025; an agreement with Idemitsu Kosan and Sumitomo Chemical in September 2025 to integrate Sumitomo's polypropylene and LLDPE businesses into Prime Polymer joint venture, aiming for annual cost savings exceeding 8 billion yen and enhanced competitiveness in polyolefins; and the sale of a majority stake in subsidiary Nippon A&L Inc. to Sojitz in May 2025 as part of portfolio transformation efforts.

Company News

APIChatGPT

  • defenseworld.net

    Contrasting Neo Performance Materials (OTCMKTS:NOPMF) and Mitsui Chemicals (OTCMKTS:MITUY)